论文信息 - Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment. - 字舞流文

Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment.

Kaleab Z. Abebe | S. Khoo | C. Dezzutti | N. Richardson-Harman | I. McGowan | D. Back | Peter E Williams | R. Stall | A. Siegel | J. Engstrom | A. Nikiforov | K. Duffill | Cory Shetler | L. Else | D. Egan | J. Egan | K. Rehman | Amy Adler | R. Brand | Beatrice Chen | S. Achilles | R. Cranston | P. Williams | Amy P. Adler | Beatrice A Chen